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Abstract
Atherosclerotic disease is currently one of the most important problems of modern medicine because it is a leading 
cause of increased morbidity, morbidity and mortality, and disability in the Western World. Atherosclerosis of the 
lower limbs (peripheral arterial disease – PAD) significantly affects the quality of life and in a considerable proportion 
of patients is a cause of disability. Radical treatment of PAD, both surgical and endovascular, aims at revascularisation 
of ischaemic tissues distal to obstructed arteries. Surveillance imaging is an important part of patient management 
after endovascular repair of PAD. Apart from availability and contraindications, challenges of imaging include cal-
cifications, flow dynamics, and stent-related artefacts. The aim of this paper was to review the current literature on 
imaging methods for follow-up after endovascular repair of atherosclerotic lesions, with special attention paid to 
novel techniques. As a non-invasive modality, ultrasound is still the first-line examination, but computed tomog-
raphy angiography remains a current state-of-the art technique for follow-up. However, since current imaging rec-
ommendations seem not to adhere to contemporary imaging possibilities, more attention should be paid to recent 
improvements in magnetic resonance angiography technology.
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Introduction
Atherosclerotic disease is currently one of the most im-
portant problems of modern medicine because it leads to 
increased morbidity, morbidity and mortality, and disa-
bility in highly industrialised countries [1]. Atheroscle-
rosis is a chronic disease of the arteries that is thought 
to be a result of a chronic inflammatory process. This 
inflammation results in endothelial damage, which starts 
a cascade of lipid deposition, fibroproliferative activation, 
and increased clotting. An ultimate product of those pro-
cesses is an atherosclerotic plaque formation that results 
in artery stenosis or occlusion, and finally in distal ischae-
mia [2-4].
Plaque formation starts as early as in childhood but 
clinically manifests later in life, when the sum of arte-
rial pathologic processes becomes sufficient to be re-
vealed clinically. Clinical symptoms may occur suddenly 
(myo cardial infarction, stroke) or progressively develop 
(ischaemic heart or brain disease and atherosclerosis of 
the lower limbs) [3]. Atherosclerosis of the lower limbs 
(peripheral arterial disease – PAD) significantly affects 
the quality of life and in a considerable proportion of pa-
tients is a cause of disability The overall disease prevalence 
of PAD is in the range of 3-10%, which increases to 15-20% 
in subjects older than 70 years of age [5]. 
Radical treatment of PAD, both surgical and endo-
vascular, aims at revascularisation of ischaemic tissues 
distal to obstructed arteries [6]. Recommendations sum-
marised in the TASC II guidelines for the treatment of 
PAD consider a heterogeneous group of patients ranging 
from claudicants to critical limb ischaemia patients [7]. 
For a subset of lesions, surgical revascularisation is still 
considered a gold standard, especially when an applicable 
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venous conduit is present. Open surgery presents high-
er patency and limb salvage rates, even though the risk 
of complications is slightly higher than for endovascular 
strategies [8]. It is, however, more and more accepted that 
an endovascular first strategy is adapted in most iliac, 
superficial femoral, and in some infrapopliteal lesions. 
The latest endovascular techniques, i.e. drug-eluting stents 
and balloons, show promising results, especially in infrap-
opliteal lesions [8]. However, as much as 40% of patients 
undergoing vein bypass require a secondary intervention 
during follow-up and an average of 1.75 repeat interventions 
per patient for a three-year period may be estimated [9]. 
Moreover, after endovascular revascularisation in 35% of 
cases a repeat intervention is necessary within a year [10]. 
These numbers underline the need for a careful follow-up 
of patients after revascularisation. Although sustained pa-
tency of treated vessels may not always be needed to achieve 
limb salvage or to obtain resolution of symptoms, surveil-
lance usually concentrates on patency monitoring [8]. 
Follow-up arterial imaging has to keep pace with in-
creasingly sophisticated methods of treatment. Therefore, 
the aim of this paper was to review the current literature 
on imaging methods for follow-up after endovascular re-
pair of atherosclerotic lesions (percutaneous angioplasty 
– PTA), with special attention paid to novel techniques. 
Challenges of imaging
A recent review showed that conventional balloon PTA, 
cryoplasty, cutting balloon angioplasty, and debulking 
(i.e. mechanical atherectomy or laser ablation) as a stand-
alone treatment for restenosis is not effective in the long 
term [11]. On the other hand, the use of covered and 
drug-eluting stents, the use of drug-coated balloons, and 
the combination of debulking and drug-coated balloon 
angioplasty seem to present promising results [11]. There-
fore, detailed restenosis imaging becomes of special im-
portance to perfectly suit an optimal treatment method.
Calcifications appear as one of last stages of evolution 
of atherosclerotic plaque. The pathomechanism of the 
plaque calcification still remains unclear, and current-
ly three hypotheses are considered, including processes 
similar to bone formation, precipitation of calcium ions, 
and activation of osteoblast-like cells [12-14]. Regardless 
of the mechanism, calcifications were considered in the 
past as a passive process associated with advanced age, 
incurable and irreversible. Current research shows that it 
is an active, controlled, and organised process in which 
hydroxyapatite (calcium phosphate) is deposited in the 
walls of the vessels in a close relation to the chronic in-
flammation that takes place in plaques [4,15]. In general, 
calcifications are a source of artefacts in imaging, which 
reduce the quality of images. A source of those artefacts 
are the physical properties of calcifications that are dis-
tinct from properties of soft tissues. In ultrasound (US), 
calcifications present much higher acoustic impedance 
than that of normal arteries, which results in acoustic 
shadowing behind the plaque. This shadowing prohib-
its both morphological analysis of the vessel structure 
(Figure 1) and flow analysis. In computed tomography 
(CT) extensive calcifications, due to high X-ray scattering 
and beam hardening, may be a source of streak artefacts. 
Those artefacts may result in a completely ineffective ves-
sel lumen analysis, especially in small arteries (Figure 2). 
Magnetic resonance imaging (MRI) is less sufficient for 
calcifications because hydroxyapatite presents just a signal 
void in this technique. Digital subtraction angiography 
(DSA) is the method least sensitive to calcification-relat-
Figure 1. Ultrasonography of the right common femoral artery. Acoustic 
shadowing (arrow) produced by calcifications prohibit arterial lumen mor-
phological analysis
Figure 2. Computed tomography angiography of the right calf. Beam scat-
tering (arrows) due to multiple small calcifications disallow stenosis analysis 
in the anterior tibial artery
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ed artefacts, but due to its invasiveness it remains the last 
choice modality for follow-up after PTA.
Flow dynamics
Advanced atherosclerosis usually affects the entire organ-
ism, including coronary arteries. Therefore, the disease 
is commonly related to heart failure that reduces cardiac 
ejection fraction and stroke volume. Those parameters in-
fluence contrast material bolus shape in arteries, i.e. they 
flatten and elongate the bolus curve. This effect has two 
major consequences in CT, MRI, and CEUS examinations: 
(i) the vessel lumen filling with contrast medium is usu-
ally suboptimal, and (ii) there is a slight possibility that 
the scanning time would not fit the vessel filling. In con-
sequence, contrast-enhanced imaging is usually of limited 
but reproducible quality, even when using bolus-tracking 
technique. 
The second important influence of flow dynamics to 
the atherosclerosis imaging is a summarising effect of 
non-significant stenoses. It is seen especially in diabetic 
patients, who present with multiple narrowings of small- 
diameter arteries. In such patients it is difficult to assess the 
individual significance of a plaque in US when the flow is 
disturbed by several previous boarder-significant lesions. 
In such cases one may not rely on either flow curve or ve-
locity analysis to diagnose the significance of the plaque. 
We “feel” the general significance of the sum of multiple 
small lesions rather than being able to directly measure it. 
Stent-related artefacts
Stents are metal scaffolds that mechanically consolidate 
the effect of angioplasty due to their radial force, which 
helps to maintain the patency of the recanalised vessel 
[16]. However, the most important complication of PTA 
is restenosis, which limits the long-term effectiveness of 
endovascular treatment. Restenosis is the artery re-nar-
rowing due to neointima proliferation, which is a mechan-
ical and cellular response of the vessel to the injury related 
to the stent placement [17]. Studies show that in the first 
year after placement of the stent, 30-55% of patients pres-
ent with restenosis [18,19]. In US and CT, stents produce 
artefacts in a similar way to calcifications because of com-
parable physical properties. However, because metals have 
higher atomic numbers than hydroxyapatite, in CT they 
produce stronger streak artefacts and also photon-star-
vation artefacts (Figure 3) that further hamper vessel lu-
men assessment and restenosis detection. Applicability of 
MRI to post-PTA follow-up is strongly dependent on the 
prosthesis composition. Nitinol stents are most suitable 
for magnetic resonance angiography (MRA) surveillance 
because Nitinol does not produce susceptibility artefacts 
that completely prohibit vessel assessment. Conversely 
nickel-alloy and stainless-steel components should not 
be examined using MRA [20]. 
Follow-up methods
Surprisingly, the value of surveillance after endovascular 
angioplasty has not undergone the same intense testing as 
that after open surgery. Currently, there are no large estab-
lished randomised controlled trials that could standardise 
diagnostic imaging in the follow-up after stent placement. 
Moreover, collateral vessel maintenance during PTA can 
further complicate the complex haemodynamic circula-
tion analysis and can lead to an underestimation of clini-
cal significance of restenosis [21].
Ultrasonography
The ankle-arm ultrasound Doppler index, which in most 
surgical centres is the basis for qualification of patients af-
ter PTA, is beyond the scope of this paper [22]. Although 
the technique uses ultrasound, it is not an imaging modal-
ity. Obviously, the ankle-arm index is an effective general 
clinical indicator of the lower leg arterial function with 
a specific predictive value to the foot perfusion [23]; how-
ever, it presents little specificity and sensitivity to particu-
lar lesions. 
In clinical practice, US is usually the modality of 
choice for follow-up after PTA [16,21,24]. It is a gener-
al consensus that the criteria for haemodynamically sig-
nificant stenosis (over 70%) in the stented artery include 
peak systolic velocity over 300 cm/s and peak velocity 
ratio across the stenosis over 3.0 [23]. However, in long 
stents these parameters may be difficult to be established. 
Moreover, because neointimal hyperplasia after PTA tends 
to be diffuse, it is recommended that additional artery im-
Figure 3. Color Doppler ultrasonography of the left external iliac artery. 
Stent-related artefacts (arrow) result in a false restenosis appearance
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aging is performed before a decision for a secondary end-
ovascular intervention, especially for iliac stents in obese 
patients [21]. US is a non-invasive and low-cost alterna-
tive of other arterial imaging modalities. The unquestion-
able advantages of US are non-invasiveness, low cost, wide 
availability, and lack of ionising radiation. The dynamic 
nature of US and Doppler US (DUS) enables identifica-
tion of flow direction and flow properties in stented arter-
ies, which is a great advantage over computed tomography 
angiography (CTA) and MRA, which present only a mo-
mentary image of vessels. The major disadvantages of US 
remain operator skill and technique dependency, equip-
ment requirements, and the above-mentioned artefacts. 
DUS in many cases has the ability to overcome its 
limitations related to calcium or stent-related artefacts. 
When the stent lumen is covered by artefacts, flow spec-
trum DUS analysis may reveal a significant in-stent reste-
nosis (Figure 3). However, this technique presents limited 
application in stenoses below 50% and in long stents. In 
extremely obese patients, when ultrasound beam pene-
tration is limited, especially when using linear probes, the 
diagnostic performance of US may also be inadequate 
[25]. In such cases, there are several solutions, including 
harmonic and crossed-beam imaging, that are available 
in modern US units as well as vendor-specific noise re-
duction techniques. However, in extreme cases, the use 
of an abdominal probe may be useful, which offers the 
best beam penetration but at the cost of lower resolution. 
Early DUS after endovascular intervention might be 
the most appropriate follow-up method, as a so-called gold 
standard, i.e. conventional angiography can underdiagnose 
residual stenosis in as much as 50% of patients [26]. How-
ever, other studies have indicated that DUS may not relia-
bly predict significant arterial occlusion because there are 
a high percentage of moderate and even severe stenoses 
that have stabilised or even resolved over time [27].
Digital subtraction angiography
DSA is still called the “gold standard” of vessel imaging 
methods according to TASC II [6]. However, the main 
drawback of this technique is its invasiveness related to 
the vessel puncture, the possibility of arterial dissection 
or distal embolisation due to atheromatous plaque frag-
mentation, the significant radiation dose, and the intra-ar-
terial contrast medium application, which, especially in 
atherosclerotic patients, may lead to contrast-induced 
nephropathy [20,28]. Moreover, similarly to plain radi-
ograph, invasive angiography can only project three-di-
mensional plaque to a two-dimensional image. Therefore, 
DSA may underestimate the real artery stenosis. Invasive 
angiography is also related to a number of complications, 
including pseudoaneurysm, arterial dissection, local 
haematoma, arteriovenous fistula, and distal embolism, 
which may additionally increase the duration of hospi-
talisation [3, 6].
The main advantage of DSA is its dynamic nature that 
enables the presentation of arterial inflow and outflow. 
Thus, it is especially useful in patients with a low cardiac 
ejection fraction and with multiple significant stenoses or 
occlusions. In such subjects, other large field-of-view mo-
dalities, including CTA and MRA, may be ineffective due 
to difficulties in establishing a proper scanning delay time. 
Nevertheless, DSA is not recommended as the primary im-
aging modality for patients with PAD and is recommended 
only when revascularisation is planned [29]. A history of 
contrast reaction should be documented before the per-
formance of angiography, and in cases of previous serious 
allergic reactions the use of carbon dioxide DSA of MRA 
has to be considered [29].
Computed tomography angiography
Although CTA is a contemporary working horse for 
lower extremity peripheral arterial disease and the mo-
dality is a subject of constant technological improvement, 
surprisingly, the most recent evidence for its accuracy was 
published in 2009. In a meta-analysis by Met et al. it was 
found that compared with intra-arterial DSA, CTA was 
an accurate modality to assess the presence and extent 
of lower extremity peripheral arterial disease in patients 
with intermittent claudication, although definitive con-
clusions could not be drawn [30]. In this meta-analysis 
CTA correctly diagnosed occlusions in 94% of segments 
and detected over 50% stenoses in 87% of segments. 
Underestimation of occlusion was found in 6% of seg-
ments, understaging of stenoses occurred in 9% and over-
staging in 4% of segments. However, it is important to 
understand the limitations of this meta-analysis. Firstly, 
although 957 patients were included, the median sample 
size of primary studies was only 33. Secondly, overall pri-
mary study quality was considered to be just moderate, 
and both publication bias and significant heterogeneity 
were detected. Finally, the median CTA slice thickness 
was as high as 2.0 mm, ranging from 0.75 mm to 5.0 mm, 
which does not fit contemporary protocols. Therefore, it 
can be concluded that the current diagnostic accuracy of 
CTA for diagnosing PAD in not known. 
CTA is the current reference standard for the follow- 
up after PTA. The modality is widely available, less opera-
tor-dependent than US, and can be performed rapidly in 
unstable patients [20]. Because contemporary CT units 
offer a very good spatial resolution, CTA enables a precise 
measurement of arterial diameters, detection of re-steno-
sis, as well as detection local PTA complications. How-
ever, due to the static nature of the modality, CTA may 
not properly present arteries in the case of severe heart 
failure or multi-level occlusions [31]. Another limitation 
of CTA is the risk of contrast-induced acute kidney injury 
(CI-AKI) [28] and potentially cancerogenous cumulative 
radiation dose [32], especially when imaging is repeated 
at follow-up. Patients after PTA, due to usually generalised 
 Imaging after endovascular repair of extremity atherosclerotic lesions
e525© Pol J Radiol 2018; 83: e521-e529
atherosclerosis, are at an increased risk for CI-AKI. For 
instance, CI-AKI was reported in 3.5% of patients sched-
uled for coronary CTA, and permanent kidney injury was 
noted in 0.2% of them [33]. However, even higher rates 
of CIN-AKI were reported for subjects undergoing DSA 
[28]. The risk related to effects of radiation is much more 
difficult to assess due to the stochastic nature of carcino-
genesis. One may say that because patients after PTA are 
usually older they do not manage to develop CTA-related 
cancer before death from other causes. This is of course 
a dilemma. Yet, the actual risk of developing cancer due to 
exposure to radiation in this group has not been estimated 
yet. Despite that, because CTA for lower extremities has to 
be performed using thin slices and the scan range is large, 
the radiation dose is significant. Therefore, it is worth con-
sidering reduction of the tube voltage to 100 or 80 kVp. 
Tube voltage reduction results in a mean dose lowering 
of up to 34% [34]. An additional advantage of low kVp 
scanning is an increased image contrast, which allows for 
iodinated contrast medium volume reduction. A disad-
vantage is the increased image noise, which reduces im-
age readability. Thus, low kVp scanning requires the use 
of iterative or model-based image reconstructions [35]. 
These techniques use multiple advanced mathematical 
operations to optimise the image by reducing the noise. 
Iterative reconstructions are widely available in contem-
porary CT scanners and should be used as a routine [20]. 
Model-based reconstructions are still a work in progress 
because the technology is expensive and time-consum-
ing, but they allow a dose reduction of as much as 73% 
as compared with low-dose conventional adaptive itera-
tive reconstruction while maintaining diagnostic accu-
racy [36]. It is also obvious that native scans have to be 
omitted. In some cases, PAD may significantly alter blood 
flow, especially distally to the knee, which results in poor 
vessel opacification. Then an additional scan of the calf is 
necessary.
Another limitation of CTA used for the follow-up 
after PTA may be stent-related artefacts. These include 
beam hardening artefacts and scatter artefacts. They ap-
pear as dark and light streaks around the stent (Figure 4), 
which may make arterial lumen analysis difficult or even 
impossible. These artefacts are stronger when high atom-
ic number metals (iron, platinum) are scanned, and less 
pronounced with low atomic number metals such as tita-
nium. Similar artefacts may be also produced by athero-
sclerotic calcifications [37]. To some extent, stent-related 
artefacts may be reduced by specific image reconstruc-
tions and dedicated software [38]. However, the most ef-
fective approach to this problem is offered by dual-energy 
CT (DECT) technique. The use of two different photon 
energies allows for artificial image reconstruction for 
a number of monoenergetic images and virtual non-en-
hanced images, as well as for metallic artefact reduction 
(Figure 5). An additional advantage of DECT is the pos-
sibility of lipid core segmentation from atherosclerot-
ic plaque [39]. Köhler et al. studied in vitro 22 different 
types of stents imaging using DECTA [40]. In this study 
the visible stent lumen diameter varied depending on 
Figure 4. Computed tomography angiography of the right common femoral 
artery. Beam hardening artefacts at the distal stent part obstruct lumen 
analysis
Figure 5. In vitro study using a set of stents filled with a solution of contrast medium. Stent-related artefacts in conventional polychromatic computed 
tomography angiography (CTA) (A) are much stronger than in dual-energy CTA reconstructed at 140 keV (B)
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stent type and scan parameters. Lumen diameter visibility 
increased with the sharpness of the reconstruction ker-
nel, and smoother kernels provided more realistic den-
sity measurements inside the stent lumen and less image 
noise. Almutairi et al. scanned 15 stents of different sizes, 
materials, and designs in monochromatic spectral imag-
ing [41]. They found that the optimal scanning protocol 
and energy level in the phantom study were GSI-48, pitch 
value 0.984, and 65 keV, which resulted in lower image 
noise and a low radiation dose but with acceptable diag-
nostic images.
Magnetic resonance angiography
MRA, in comparison with DSA and CTA, eliminates 
exposure to ionising radiation and the risk of CIN-AKI. 
Unlike US and CTA, MRA is unaffected by arterial cal-
cifications [29]. For the purpose of lower extremity im-
aging, contrast-enhanced MRA is used. Contrast media 
generate a high intravascular SNR, which is largely unaf-
fected by inflow [42]. CE-MRA has thus improved spatial 
resolution and reduced scan time compared with time-
of-flight MRA and phase-contrast MRA. On the other 
hand, CE-MRA is limited by the largest available field of 
view (FOV), which is below 50 cm, and by the presence of 
venous signal, which increases with increasing time after 
contrast injection [43]. The FOV limitation is overcome 
by the use of a stepping-table movement, but it requires 
precise control of bolus timing to ensure a high concen-
tration of contrast medium at each station during acquisi-
tion. Otherwise, image quality may be reduced because of 
vascular overlap resulting from venous return, especially 
distally to the knee [44,45]. Finally, common limitations 
of MRI have to be mentioned, including claustrophobia, 
the presence of metallic implants or foreign bodies, and 
the risk of nephrogenic systemic fibrosis in renal insuffi-
ciency patients. 
Follow-up after stent placement using MRA is a chal-
lenge [46]. Susceptibility artefacts occurring at the ends 
of stents and false lumen narrowing are well-described 
phenomena, and therefore MRA tends to overestimate the 
degree of stenosis [29,47] (Figure 6). Artefacts are related 
to blood flow, magnetic susceptibility, and radiofrequen-
cy shielding [48,49]. Flow-related artefacts are produced 
by turbulent and slow flow of blood and may be more 
frequent at the distal end of the stent and in the case of 
restenosis. A solution for this kind of artefact would be 
the use of short TR, short TE, and flow-compensating 
gradients [48,49]. Differences of magnetic susceptibility 
between soft tissues and stents result in magnetic field 
inhomogeneities, which in turn lead to image distortion 
and regional signal loss caused by intravoxel dephasing 
[46]. The magnetic susceptibility thus determines MRI 
compatibility of stents, but there are no MRI safety issues 
with currently manufactured peripheral vascular stents at 
normal diagnostic field strengths [50]. Adams et al. test-
ed 15 different stents in vitro and in vivo at 1.5 T [51]. In 
their material, stents made of nitinol did not give artefacts 
affecting the interpretation of images, while vessels with 
stainless steel stents were not appropriate for analysis. 
Similar results were reported by Lambertus et al., who also 
found that the smallest artefacts were seen when scanning 
with the use of short echo times and stents aligned with 
the main magnetic field direction [52]. A comparative 
CTA and MRA phantom study by Maintz et al. came to 
the conclusion that knowledge of stent composition is es-
sential to properly choose the imaging follow-up method 
after PTA. Stents made of steel, nitinol, and cobalt should 
be controlled using CTA, while implants composed of 
tantalum should be imaged with MRA [53]. However, 
recent evidence suggests that inversion recovery with 
on-resonant water suppression (IRON) sequence would 
allow for visualisation of nitinol stents with MRA [54].
Optimal modality selection
A fundamental difference of follow-up after endovascular 
treatment comes from the obvious challenge to localise 
the treated arterial segment precisely and not to confound 
restenosis or re-occlusion with progressive arterial disease 
elsewhere on the same artery [55]. This is reflected by the 
distinction between target lesion re-intervention and tar-
get extremity re-intervention as a clinically important 
end-point. Moreover, the preservation of collateral vessels 
during recanalisation may attenuate the clinical impact 
of restenosis or reocclusion [55]. Overall, the assessment 
after PTA may be similar to the protocol after open arteri-
Figure 6. Magnetic resonance angiography. Susceptibility artefacts result in 
a false image of in-stent restenosis in the right iliac arteries (arrows)
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al bypass, but particular schedules are significantly influ-
enced by institutional bias [56]. Most reports recommend 
patient evaluation every three months in the first year, and 
every six months thereafter.
Although DSA is still considered the gold standard 
for arterial imaging [6], it is obvious that the invasiveness 
and the cost of the procedure strongly limit its applica-
tion for follow-up after endovascular treatment [20]. In 
recent guidelines by the American College of Cardiology 
and American Heart Association, the strongest evidence 
(class of recommendation I/level of evidence C-EO) for 
longitudinal follow-up of patients with PAD, who have 
undergone lower extremity revascularisation, was given to 
clinical evaluation and ankle/brachial index (ABI) meas-
urement [57]. However, lower grade evidence (IIa/C-LD) 
indicates that duplex US is reasonable for routine sur-
veillance after endovascular procedures in patients with 
PAD. The statement says that several studies have devel-
oped duplex ultrasound diagnostic criteria for diagnosing 
restenosis at the site of endovascular revascularisation, but 
diagnostic criteria need to be customised to the location 
and method of revascularisation [57]. The optimal tim-
ing for surveillance after endovascular procedures is still 
unclear. Surprisingly, there are limited outcome data on 
routine duplex surveillance versus clinical surveillance 
plus ABI after endovascular revascularisation [57]. Some 
authors indicate that the value of duplex ultrasound may 
be greater in cases with higher rates of restenosis, such as 
very long lesions or occlusions [58]. 
European guidelines indicate that an early (six weeks 
to six months) colour duplex scan may be useful after 
endovascular revascularisation, to identify patients at 
risk for failure [55]. However, there is no evidence sup-
porting routine long-term CD surveillance after endovas-
cular revascularisation because best level evidence does 
not support the use of CD imaging compared to clinical 
follow-up with ABI every three months in patients with 
prosthetic bypass. However, the guidelines indicate that 
the role and duration of CD surveillance after endovas-
cular treatment including use of stents, subintimal recan-
alisation, and endarterectomy devices should be better 
evaluated as compared to clinical surveillance with ABI 
measurements [55]. 
In the context of long-term follow-up, special atten-
tion has to be paid to three groups of patients, includ-
ing diabetics, chronic kidney disease patients, and func-
tionally impaired subjects. A significant proportion of 
revascularised patients are diabetic and therefore may 
be challenging to manage. Diabetes results in advanced 
peripheral vascular disease and in limited primary paten-
cy rates. Diabetic patients are likely to benefit from close 
clinical and colour duplex-scan surveillance because 
primary patency rates are low, and the ankle-brachial 
pressure index may be unreliable [59]. Therefore, an un-
common problem in diabetics comes in the form of flow 
disturbances that hamper the proper assessment of the 
significance of multiple small stenoses. Moreover, diabet-
ics present a common kidney function impairment, which 
limits the application of CTA and MRA. Patients with 
end-stage kidney disease present a significantly increased 
risk of amputation after revascularisation [60]. Further-
more, significant renal function impairment remains an 
important limitation of contrast medium administration 
in CT and MRI. In elderly patients, quality of care after 
PTA is not solely determined by the traditional measures 
of patency and limb salvage but particularly by functional 
outcomes [55]. 
Conclusions
Surveillance imaging is an important part of patient man-
agement after PTA. As a non-invasive modality, US is still 
the first-line examination, but CTA remains a state-of-the 
art technique for follow-up. However, since current im-
aging recommendations do not adhere to contemporary 
imaging possibilities, more attention should be paid to 
recent improvements in MRA technology.
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